• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑转移瘤患者下丘脑-垂体区域转移的发生率。

Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases.

机构信息

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.

Private Practice of Radiation Oncology, Hannover, Germany.

出版信息

Radiat Oncol. 2019 Aug 27;14(1):152. doi: 10.1186/s13014-019-1337-6.

DOI:10.1186/s13014-019-1337-6
PMID:31455428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712746/
Abstract

AIM

To quantify the prevalence of brain metastases involving the hypothalamic-pituitary (HT-P) area.

INTRODUCTION

Cognitive impairment and fatigue are common side effects of whole brain irradiation (WBI) comprising the quality of life (QoL) for survivors. While the former is related to radiation-induced hippocampal injury, the latter could be secondary to hormonal disbalance as a consequence of radiation of the HT-P area. Thus, sparing both regions from higher irradiation doses could reduce these sequelae.

METHODS

T1 contrast medium enhanced magnetic resonance imaging (MRI) scans of 865 patients with brain metastases (4,280 metastases) were reviewed. HT-P area was individually contoured with a margin of 5 mm in order to evaluate the prevalence of brain metastases in this region.

RESULTS

Involvement of the hypothalamic region was found in 26 patients (involvement rate of 3% for patients and 1% for metastases), involvement of the pituitary gland in 9 patients (1% for patients and < 1% for metastases). Binary logistical regression analysis revealed the presence of > 10 brain metastases as the only factor associated with hypothalamic involvement while no distinct factor was associated with an involvement of the pituitary gland.

CONCLUSION

The low prevalence of metastases within the HT-P area in patients with brain metastases calls for further studies examining whether sparing of this region might improve patients QoL.

摘要

目的

定量分析涉及下丘脑-垂体(HT-P)区域的脑转移瘤的发生率。

简介

全脑照射(WBI)会导致认知障碍和疲劳,这是脑转移患者常见的副作用,会降低患者的生活质量(QoL)。前者与放射诱导的海马损伤有关,而后者可能是由于 HT-P 区域放射导致的激素失衡引起的。因此,使这两个区域免受更高剂量的辐射可能会减少这些后遗症。

方法

回顾了 865 例脑转移患者(4280 个转移灶)的 T1 对比剂增强磁共振成像(MRI)扫描。对 HT-P 区域进行单独勾画,边界为 5mm,以评估该区域脑转移瘤的发生率。

结果

26 例患者(患者发生率为 3%,转移灶发生率为 1%)存在下丘脑受累,9 例患者(患者发生率为 1%,转移灶发生率<1%)存在垂体受累。二元逻辑回归分析显示,存在>10 个脑转移灶是与下丘脑受累相关的唯一因素,而与垂体受累无关的明确因素。

结论

脑转移患者 HT-P 区域转移灶的低发生率需要进一步研究,以确定是否保护该区域可以改善患者的 QoL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea7/6712746/3244d90fa0a6/13014_2019_1337_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea7/6712746/3244d90fa0a6/13014_2019_1337_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea7/6712746/3244d90fa0a6/13014_2019_1337_Fig1_HTML.jpg

相似文献

1
Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases.脑转移瘤患者下丘脑-垂体区域转移的发生率。
Radiat Oncol. 2019 Aug 27;14(1):152. doi: 10.1186/s13014-019-1337-6.
2
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.全脑放疗中保护海马体和下丘脑-垂体区域:一项容积调强弧形治疗计划研究。
BMC Cancer. 2020 Jun 30;20(1):610. doi: 10.1186/s12885-020-07091-x.
3
Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.使用调强弧形放疗对多发脑转移瘤进行海马区保护及同步整合加量的全脑放疗治疗计划策略
Med Dosim. 2016;41(4):315-322. doi: 10.1016/j.meddos.2016.08.001. Epub 2016 Sep 28.
4
Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases.对四种全脑放射治疗方法进行剂量学评估,包括避免海马体和内耳的方法以及同时进行的适形调强放疗,适用于有限的脑转移瘤。
Radiat Oncol. 2019 Mar 15;14(1):46. doi: 10.1186/s13014-019-1255-7.
5
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).全脑放疗联合海马保护和剂量递增治疗转移瘤:神经认知测试和生物学成像(HIPPORAD)-一项 II 期前瞻性随机多中心试验(NOA-14、ARO 2015-3、DKTK-ROG)。
BMC Cancer. 2020 Jun 8;20(1):532. doi: 10.1186/s12885-020-07011-z.
6
Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.海马区保留的全脑放疗与同步整合加量放疗对比立体定向放射外科加量放疗:一项剂量学对比计划研究
Asian Pac J Cancer Prev. 2016;17(9):4233-4235.
7
Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.全脑放疗联合海马保护和颅内多发转移瘤的剂量递增:治疗方案的规划研究。
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):264-70. doi: 10.1016/j.ijrobp.2012.02.036. Epub 2012 Apr 18.
8
Initial experiences with hippocampus-sparing whole-brain radiotherapy for lung cancer patients.肺癌患者保留海马体的全脑放疗的初步经验。
Acta Oncol. 2019 Oct;58(10):1540-1542. doi: 10.1080/0284186X.2019.1632479. Epub 2019 Jul 15.
9
Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.全脑放疗期间海马回避对小细胞肺癌患者有风险吗?海马转移率及相关危险因素。
Technol Cancer Res Treat. 2017 Dec;16(6):1202-1208. doi: 10.1177/1533034617742301. Epub 2017 Nov 21.
10
Estimating the probability of underdosing microscopic brain metastases with hippocampal-sparing whole-brain radiation.评估采用保留海马的全脑放疗对微小脑转移灶剂量不足的概率。
Radiother Oncol. 2016 Aug;120(2):248-52. doi: 10.1016/j.radonc.2016.05.030. Epub 2016 Jul 9.

引用本文的文献

1
Breaking boundaries: role of the brain barriers in metastatic process.突破界限:脑屏障在转移过程中的作用。
Fluids Barriers CNS. 2025 Jan 8;22(1):3. doi: 10.1186/s12987-025-00618-z.
2
A Biphasic Presentation of Diffuse Large B-cell Lymphoma Metastasis to the Hypothalamus-pituitary Axis: A Case Report and Literature Review.弥漫性大B细胞淋巴瘤转移至下丘脑-垂体轴的双相表现:一例报告及文献综述
J Community Hosp Intern Med Perspect. 2024 Sep 9;14(5):128-134. doi: 10.55729/2000-9666.1393. eCollection 2024.
3
Frequency of metastases within the hypothalamic-pituitary area and the associated high-risk factors in patients with brain metastases.

本文引用的文献

1
Simultaneously avoiding the hippocampus and hypothalamic-pituitary axis during whole brain radiotherapy: A planning study.全脑放疗期间同时避开海马体和下丘脑 - 垂体轴:一项计划研究。
Med Dosim. 2019;44(2):130-135. doi: 10.1016/j.meddos.2018.04.004. Epub 2018 May 31.
2
Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.颅脑放疗对儿童急性淋巴细胞白血病幸存者垂体-下丘脑区域的长期影响
Curr Treat Options Oncol. 2016 Sep;17(9):50. doi: 10.1007/s11864-016-0426-0.
3
Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours.
脑转移患者下丘脑 - 垂体区域内转移灶的发生率及相关高危因素
Front Neurol. 2023 Nov 30;14:1285662. doi: 10.3389/fneur.2023.1285662. eCollection 2023.
4
Effects of Hippocampal Sparing Radiotherapy on Brain Microstructure-A Diffusion Tensor Imaging Analysis.海马体保留放疗对脑微结构的影响——扩散张量成像分析
Brain Sci. 2022 Jul 4;12(7):879. doi: 10.3390/brainsci12070879.
5
Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review.美金刚预防放射性脑损伤:一篇叙述性综述。
Cancers (Basel). 2022 May 31;14(11):2736. doi: 10.3390/cancers14112736.
6
PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology.临床成人肿瘤学中的PET-CT——第五部分。头颈部及神经肿瘤学
Cancers (Basel). 2022 May 31;14(11):2726. doi: 10.3390/cancers14112726.
7
The Advantage of Proton Therapy in Hypothalamic-Pituitary Axis and Hippocampus Avoidance for Children with Medulloblastoma.质子治疗在髓母细胞瘤患儿下丘脑-垂体轴及海马保护方面的优势
Int J Part Ther. 2021 Aug 2;8(3):43-54. doi: 10.14338/IJPT-21-00001.1. eCollection 2022 Winter.
8
HMGB1 Promotes the Proliferation and Metastasis of Lung Cancer by Activating the Wnt/β-Catenin Pathway.高迁移率族蛋白 B1 通过激活 Wnt/β-连环蛋白通路促进肺癌的增殖和转移。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948054. doi: 10.1177/1533033820948054.
9
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.全脑放疗中保护海马体和下丘脑-垂体区域:一项容积调强弧形治疗计划研究。
BMC Cancer. 2020 Jun 30;20(1):610. doi: 10.1186/s12885-020-07091-x.
成人期非垂体脑肿瘤头颅放疗后的垂体功能障碍
Clin Endocrinol (Oxf). 2016 Mar;84(3):372-9. doi: 10.1111/cen.12969. Epub 2015 Nov 24.
4
INITIAL SYMPTOMATIC PITUITARY METASTASIS IN A PATIENT WITH PROSTATE FOAMY GLAND CARCINOMA: TAILORING SAFE AND EFFECTIVE THERAPY.一例前列腺泡沫状腺癌患者的初始症状性垂体转移:定制安全有效的治疗方案
Acta Clin Croat. 2015 Jun;54(2):243-8.
5
Radiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg.鼻咽癌放疗所致垂体功能减退:冰山一角。
Exp Clin Endocrinol Diabetes. 2015 Jul;123(7):411-8. doi: 10.1055/s-0035-1549963. Epub 2015 May 26.
6
Effect of cancer treatment on hypothalamic-pituitary function.癌症治疗对下丘脑-垂体功能的影响。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):568-76. doi: 10.1016/S2213-8587(15)00008-X. Epub 2015 Apr 12.
7
Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.儿童和青少年期癌症成年幸存者的不良内分泌结局的筛查和管理。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):545-55. doi: 10.1016/S2213-8587(15)00038-8. Epub 2015 Apr 12.
8
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.接受头颈部放疗的癌症幸存者中,激素功能障碍很常见。
J Cancer Surviv. 2015 Dec;9(4):630-40. doi: 10.1007/s11764-015-0439-x. Epub 2015 Mar 7.
9
Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice.成人及儿童脑部的危及器官及其剂量限制:放射肿瘤学家日常实践中的勾画指南。
Radiother Oncol. 2015 Feb;114(2):230-8. doi: 10.1016/j.radonc.2015.01.016. Epub 2015 Feb 17.
10
Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.儿童癌症成年幸存者接受颅脑放疗后的垂体前叶功能减退:来自圣裘德终身队列研究的报告
J Clin Oncol. 2015 Feb 10;33(5):492-500. doi: 10.1200/JCO.2014.56.7933. Epub 2015 Jan 5.